Natchus; Michael George

Patent Applications and Registrations

Patent applications and USPTO patent grants for Natchus; Michael George.The latest application filed is for "substituted cyclic amine metalloprotease inhibitors".

Company Profile

0.18.23

Natchus; Michael George - Alpharetta GA
Natchus, Michael George - Glendale OH
Natchus; Michael George - Cincinnati OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Graphical user interface for a display screen or a portion thereof Grant D685,387 - Kurtkaya , et al. July 2, 2	2013-07-02
Heterocyclic side chain containing, n-substituted metalloprotease inhibitors Grant 6,949,545 - Pikul , et al. September 27, 2	2005-09-27
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,919,346 - Clark , et al. July 19, 2	2005-07-19
Substituted cyclic amine metalloprotease inhibitors App 20050154019 - Natchus, Michael George ; et al.	2005-07-14
Substituted cyclic amine metalloprotease inhibitors App 20050137248 - Natchus, Michael George ; et al.	2005-06-23
Substituted cyclic amine metalloprotease inhibitors App 20050101567 - Natchus, Michael George ; et al.	2005-05-12
Substituted cyclic amine metalloprotease inhibitors Grant 6,872,742 - Natchus , et al. March 29, 2	2005-03-29
Substituted cyclic amine metalloprotease inhibitors Grant 6,858,628 - Natchus , et al. February 22, 2	2005-02-22
Difluorobutyric acid metalloprotease inhibitors Grant 6,852,751 - Pikul , et al. February 8, 2	2005-02-08
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,790,846 - Clark , et al. September 14, 2	2004-09-14
Triazole compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,787,555 - Tullis , et al. September 7, 2	2004-09-07
Beta disubstituted metalloprotease inhibitors App 20040142975 - Pikul, Stanislaw ; et al.	2004-07-22
Substituted cyclic amine metalloprotease inhibitors App 20040138260 - Natchus, Michael George ; et al.	2004-07-15
Dihetero-substituted metalloprotease inhibitors Grant 6,762,198 - Cheng , et al. July 13, 2	2004-07-13
Heterocyclic side chain containing, n-substituted metalloprotease inhibitors App 20040127498 - Pikul, Stanislaw ; et al.	2004-07-01
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity App 20040122025 - Clark, Michael Philip ; et al.	2004-06-24
6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines Grant 6,730,668 - Clark , et al. May 4, 2	2004-05-04
Triazole compounds useful in treating diseases associated with unwanted cytokine activity Grant 6,727,364 - Tullis , et al. April 27, 2	2004-04-27
Beta disubstituted metalloprotease inhibitors Grant 6,696,456 - Pikul , et al. February 24, 2	2004-02-24
1,2-dihydropyrazol-3-ones which controls inflammatory cytokines Grant 6,677,337 - Laufersweiler , et al. January 13, 2	2004-01-13
1,2-dihydropyrazol-3-ones which controls inflammatory cytokines App 20030225082 - Laufersweiler, Matthew John ; et al.	2003-12-04
Dihetero-substituted metalloprotease inhibitors App 20030225074 - Cheng, Menyan ; et al.	2003-12-04
Substituted cyclic amine metalloprotease inhibitors App 20030191163 - Natchus, Michael George ; et al.	2003-10-09
Heterocyclic metalloprotease inhibitors App 20030186958 - De, Biswanath ; et al.	2003-10-02
Heterocyclic side chain containing metalloprotease inhibitors App 20030171400 - Pikul, Stanislaw ; et al.	2003-09-11
Carbocyclic side chain containing metalloprotease inhibitors App 20030162778 - Natchus, Michael George ; et al.	2003-08-28
Carbocyclic side chain containing, N-substituted metalloprotease inhibitors App 20030144292 - Natchus, Michael George ; et al.	2003-07-31
Heterocyclic side chain containing, n-substituted metalloprotease inhibitors App 20030139414 - Pikul, Stanislaw ; et al.	2003-07-24
6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines App 20030134867 - Clark, Michael Philip ; et al.	2003-07-17
1,3-Diheterocyclic metalloprotease inhibitors App 20030130271 - Pikul, Stanislaw ; et al.	2003-07-10
Substituted cyclic amine metalloprotease inhibitors App 20030105153 - Natchus, Michael George ; et al.	2003-06-05
Triazole compounds useful in treating diseases associated with unwanted cytokine activity App 20030100558 - Tullis, Joshua Spector ; et al.	2003-05-29
Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity App 20030096814 - Clark, Michael Philip ; et al.	2003-05-22
Heterocyclic metalloprotease inhibitors Grant 6,545,038 - De , et al. April 8, 2	2003-04-08
Triazole compounds useful in treating diseases associated with unwanted cytokine activity App 20030013712 - Tullis, Joshua Spector ; et al.	2003-01-16
Substituted cyclic amine metalloprotease inhibitors App 20020072517 - Natchus, Michael George ; et al.	2002-06-13
Substituted cyclic amine metalloprotease inhibitors App 20020061877 - Natchus, Michael George ; et al.	2002-05-23
Substituted pyrrolidine hydroxamate metalloprotease inhibitors Grant 6,329,418 - Cheng , et al. December 11, 2	2001-12-11
Acyclic metalloprotease inhibitors Grant 6,218,389 - Almstead , et al. April 17, 2	2001-04-17
Lactam-containing hydroxamic acids Grant 5,672,598 - De , et al. September 30, 1	1997-09-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.